Prognostic factors and secondary malignancies in childhood medulloblastoma

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 7, 2001, Pages 431-436

  Stavrou, Theodora ^b   Bromley, Christina M ^b   Stacy Nicholson, H ^a   Byrne, Julianne ^a   Packer, Roger J ^a   Goldstein, Alisa M ^b   Reaman, Gregory H ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Medulloblastoma; Nevoid basal cell carcinoma syndrome; Prognostic factors; Secondary malignancies

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; LOMUSTINE; METHOTREXATE; VINCRISTINE;

ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; BRAIN VENTRICLE PERITONEUM SHUNT; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MENINGIOMA; METASTASIS; POSTERIOR FOSSA; PRIORITY JOURNAL; PROGNOSIS; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION SICKNESS; SECOND CANCER; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; CARCINOMA, BASAL CELL; CEREBELLAR NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, RADIATION-INDUCED; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 0034761908     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200110000-00008     Document Type: Article

References (42)

1. rd ed. Philadelphia: Lippincott-Raven, 1997: 651-6.
2. Davis FG, Freels S, Grutsch J, et al. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histologic type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 1998; 88: 1-10.
3. Hughes EN, Shillito J, Sallan SE, et al. Medulloblastoma at the Joint Center for Radiation Therapy between 1968 and 1984: The influence of radiation dose on the patterns of failure and survival. Cancer 1988; 61: 1992-8.
4. Evans AE, Jenkin RDT, Sposto R, et al. The treatment of medulloblastoma: Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 1990; 72: 572-82.
5. Tait DM, Thornton-Jones H, Bloom HJG, et al. Adjuvant chemotherapy for medulloblastoma: The first multicenter control trial of the International Society of Pediatric Oncology (SIOP I). Eur J Cancer 1990; 26: 464-9.
6. Packer RJ, Sutton LN, Elterman R, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, vincristine chemotherapy. J Neurosurg 1994; 81: 690-8.
7. David KM, Casey ATH, Hayward RD, et al. Medulloblastoma: is the 5 year survival rate improving? J Neurosurg 1997; 86: 13-21.
8. Albright AL, Wisoff JH, Zeltzer PM, et al. Effects of medulloblastoma resections on outcome in children: A report from the Children’s Cancer Group. Neurosurgery 1996; 38: 265-71.
9. Weil MD, Lamborn K, Edwards MSB, et al. Influence of a child’s sex on medulloblastoma outcome. JAMA 1998; 279: 1474-6.
10. Zerbini C, Gelber RD, Weinberg D, et al. Prognostic factors in medulloblastoma, including DNA ploidy. J Clin Oncol 1993; 11: 616-22.
11. Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol 1999; 17: 832-45.
12. Jenkin D, Greenberg M, Hoffman H, et al. Brain tumors in children: long-term survival after radiation treatment. Int J Radiat Oncol Biol Phys 1995; 31: 445-51.
13. Johnson DL, McCabe MA, Nicholson HS, et al. Quality of long-term survival in young children with medulloblastoma. J Neurosurg 1994; 80: 1004-10.
14. Goldstein AM, Yuen J, Tucker MA. Second cancers after medulloblastoma: population-based results from the United States and Sweden. Cancer Causes Control 1997; 8: 865-71.
15. Chang CH, Housepian EM, Herbert Jr, C et al. An operative staging system on megavoltage radiotherapeutic technique for cerebellar medulloblastoma. Radiology 1969; 93: 1351-9.
16. Ries LAG, Kosary CL, Hankey BF, et al. SEER Cancer Statistics Review, 1973-1996, National Cancer Institute. Bethesda, MD, 1999.
17. Muir CS, Storm HH, Polednak A. Brain and other nervous system tumors. In: Doll R, Fraumeni Jr, JF Muir CS, eds. Trends in Cancer Incidence and Mortality. Plainview, NY: Cold Spring Harbor Laboratory Press, 1994. Also cited in: Cancer Surv 1994;19/20:369-392.
18. Helseth A. Incidence and survival of intracranial meningioma patients in Norway 1963-1992. Neuroepidemiol 1997; 16: 53-9.
19. Magnus K. The Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer. Int J Cancer 1991; 47: 12-9.
20. Boice JD Jr, Lubin JH, Preston DL. Epidemiologic Analysis With a Personal Computer (EPITOME). Washington, DC: US Government Printing Office; 1991. NIH Publication 91-3180.
21. Allison, Paul D. Survival Analysis Using the SAS System: A Practical Guide. Cary, NC: SAS Institute, 1995.
22. Collins VP. Wilms’ tumor: Its behavior and prognosis. J La State Med Soc 1955; 107: 474-80.
23. Bloom HJG, Wallace ENK, Henk JM. The treatment and prognosis of medulloblastoma in children. AJR Am J Roentgenol 1969; 105: 43-62.
24. Gorlin RJ. Nevoid basal cell carcinoma syndrome. Medicine 1987; 66: 98-113.
25. Sutton LN, Phillips PC, Molloy PT. Surgical management of medulloblastoma. J Neurooncol 1996; 29: 9-21.
26. Brown WD, Tavare JC, Sobel EL, et al. Medulloblastoma and Collins’ Law: A critical review of the concept of a period of risk for tumor recurrence and patient survival. Neurosurgery 1995; 36: 691-7.
27. Friedberg MH, David O, Adelman LS, et al. Recurrence of medulloblastoma: violation of Collins’ law after two decades. Surg Neurol 1997; 47: 571-4.
28. Lefkowitz IB, Packer RJ, Ryan SG, et al. Late recurrence of primitive neuroectodermal tumor/medulloblastoma. Cancer 1988; 62: 826-30.
29. Lefkowitz IB, Packer RJ, Siegel KR, et al. Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine. Cancer 1990; 65: 412-7.
30. Wara WM, Le QTX, Sneed PK, et al. Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 1994; 30: 551-6.
31. Bouffet E, Doz F, Demaille MC, et al. Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse? Br J Cancer 1998; 77: 1321-6.
32. Kiltie AE, Lashford LS, Gattamaneni HR. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Med Pediatr Oncol 1997; 28: 348-54.
33. Jenkin D. The radiation treatment of medulloblastoma. J Neurooncol 1996; 29: 45-54.
34. Pearl GS, Mirra SS, Miles ML. Glioblastoma multiforme occurring 13 years after treatment of a medulloblastoma. Neurosurgery 1980; 6: 546-51.
35. Schmidbauer M, Budka H, Bruckner R, et al. Glioblastoma developing at the site of a cerebellar medulloblastoma treated 6 years earlier. J Neurosurg 1987; 67: 915-8.
36. Dweik A, Maheut-Lourmiere J, Lioret E, et al. Radiation-induced meningioma. Childs Nerv Syst 1995; 11: 661-3.
37. Starshak RJ. Radiation-induced meningioma in children: report of two cases and review of the literature. Pediatr Radiol 1996; 26: 537-41.
38. Duffner PK, Krischer JP, Horowitz ME, et al. Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: A Pediatric Oncology Group Study. Ann Neurol 1998; 44: 313-6.
39. Evans DGR, Farndon PA, Burnell LD, et al. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 1991; 64: 959-61.
40. Strong LC. Genetic and environmental interactions. Cancer 1977; 40: 1861-6.
41. O’ Malley S, Weitman D, Olding M, et al. Multiple neoplasms following craniospinal irradiation for medulloblastoma in a patient with nevoid basal cell carcinoma syndrome. J Neurosurg 1997; 86: 286-8.
42. Korczak JF, Brahim JS, DiGiovanna JJ, et al. Nevoid basal cell carcinoma syndrome with medulloblastoma in an African-American boy: A rare case illustrating gene-environment interaction. Am J Med Genet 1997; 69: 309-14.